A novel, safe, fast and efficient treatment for Her2-positive and negative bladder cancer utilizing an EGF-anthrax toxin chimera. [electronic resource]
Producer: 20200219Description: 449-460 p. digitalISSN:- 1097-0215
- Administration, Intravesical
- Animals
- Antigens, Bacterial -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Apoptosis -- drug effects
- Bacterial Toxins -- administration & dosage
- Cell Line, Tumor
- Dogs
- Drug Screening Assays, Antitumor
- Epidermal Growth Factor -- administration & dosage
- Female
- Humans
- Immunotoxins -- administration & dosage
- Male
- Mice
- Primary Cell Culture
- Receptor, ErbB-2 -- metabolism
- Treatment Outcome
- Urinary Bladder Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.